MCAPS Stock Overview

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. More details

MCAPS fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (30.2x) is below the Life Sciences industry average (39x)

Earnings grew by 21% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

MedCap AB (publ) Competitors

hVIVO

AIM:HVO

UK£130.0m

Ergomed

AIM:ERGO

UK£701.1m

C4X Discovery Holdings

AIM:C4XD

UK£30.3m

Bioventix

AIM:BVXP

UK£172.2m

Price History & Performance

Summary of share price highs, lows and changes for MedCap
Historical stock prices
Current Share Price	SEK 272.00
52 Week High	SEK 272.00
52 Week Low	SEK 192.60
Beta	0.64
1 Month Change	0%
3 Month Change	2.06%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	66.26%

Recent updates

Shareholder Returns

	MCAPS	GB Life Sciences	GB Market
7D	0%	-2.8%	1.3%
1Y	n/a	-29.1%	4.3%

Return vs Industry: Insufficient data to determine how MCAPS performed against the UK Life Sciences industry.

Return vs Market: Insufficient data to determine how MCAPS performed against the UK Market.

Price Volatility

Is MCAPS's price volatile compared to industry and market?
MCAPS volatility
MCAPS Average Weekly Movement	n/a
Life Sciences Industry Average Movement	7.8%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.5%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: MCAPS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MCAPS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	478	Anders Dahlberg	medcap.se/en/

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe.

MedCap AB (publ) Fundamentals Summary

How do MedCap's earnings and revenue compare to its market cap?
MCAPS fundamental statistics
Market cap	SEK 3.71b
Earnings (TTM)	SEK 122.80m
Revenue (TTM)	SEK 1.24b

30.2x

P/E Ratio

3.0x

P/S Ratio

Is MCAPS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCAPS income statement (TTM)
Revenue	SEK 1.24b
Cost of Revenue	SEK 518.00m
Gross Profit	SEK 723.40m
Other Expenses	SEK 600.60m
Earnings	SEK 122.80m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Jul 28, 2023

Earnings per share (EPS)	8.29
Gross Margin	58.27%
Net Profit Margin	9.89%
Debt/Equity Ratio	16.7%

How did MCAPS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/07/11 12:27
End of Day Share Price	2023/04/13 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedCap AB (publ) is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Bjorn Rydell	ABG Sundal Collier Sponsored
Hans Mähler	Nordea Markets
null null	Nordea Markets